CA Patent

CA2748856C — Riluzole aqueous suspensions

Assigned to Italfarmaco SpA · Expires 2017-01-03 · 9y expired

What this patent protects

Physically and chemically stable aqueous suspensions of riluzole are disclosed together with the manufacturing methods thereof. Such aqueous suspensions comprise riluzole in particle form and at least a wetting agent, preferably a surfactant. Riluzole is in amounts from about 0.1…

USPTO Abstract

Physically and chemically stable aqueous suspensions of riluzole are disclosed together with the manufacturing methods thereof. Such aqueous suspensions comprise riluzole in particle form and at least a wetting agent, preferably a surfactant. Riluzole is in amounts from about 0.1% to about 20% w/v and has an average particle size lower than 200 µm; such suspensions are devoid of the known local (mouth) anaesthetic effects of riluzole.

Drugs covered by this patent

Patent Metadata

Patent number
CA2748856C
Jurisdiction
CA
Classification
—
Expires
2017-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Italfarmaco SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.